Influence of Ultrasonographic Hydro-dissection With Glucose 5% on Nerve Block Efficiency (Hydro-Echo)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The real-time visualization of a needle and nerve during an ultrasound-guided nerve block can be challenging. These difficulties may partly explain the systemic complications of local anesthetics under ultrasound. Injection of small amounts of a solution around the anesthetized nerve (hydro-dissection) has been proposed to enhance contrast outlining its borders and also to improve the visualization of the needle tip. The glucose solution 5% solution is interesting because it allows, unlike saline, to maintain the motor response with neurostimulation. The hydro-dissection can be particularly useful when one suspect hypoechoic vessels near the nerve to be anesthetized. Thereby, the nerve well demarcated and separated from the vessels, injection of local anesthetic is performed in the circumferential diffusion space (like a small pocket) without redirecting needle.
The influence of this hydro-dissection on the nerve block efficiency is unknown. The nerve block quality can be improved because the entire anesthetic is injected in contact with the nerve, but it can also be reduced due to the dilution of the local anesthetic by the glucose solution.
In this randomized study, the investigators test the hypothesis that hydro-dissection does not alter the nerve block onset time.
| Condition | Intervention | Phase |
|---|---|---|
|
Nerve Block |
Procedure: median nerve block Procedure: median nerve block after hydro-dissection |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Influence of Ultrasonographic Hydro-dissection With Glucose 5% Solution on Median Nerve Block Efficiency: a Prospective and Randomized Study |
- Onset time of sensory blockade (light touch test: total loss of sensation at the two distal phalanges of index) [ Time Frame: 30 minutes after injection ] [ Designated as safety issue: No ]
- Onset time of sensory blockade (cold test at index finger and thenar eminence) [ Time Frame: 30 minutes after injection ] [ Designated as safety issue: No ]
- Onset time (light touch test at thenar eminence) [ Time Frame: 30 minutes after injection ] [ Designated as safety issue: No ]
- Onset time for motor blockade [ Time Frame: 30 minutes after injection ] [ Designated as safety issue: No ]
- Success rate (% of patients with total light touch block at index finger within 30 min evaluation period) [ Time Frame: 30 minutes after injection ] [ Designated as safety issue: No ]
- Successful surgical anesthesia [ Time Frame: 30 minutes after injection ] [ Designated as safety issue: No ]
- Duration of nerve blockade [ Time Frame: 12 hours ] [ Designated as safety issue: No ]
- Nerve block complication [ Time Frame: one month ] [ Designated as safety issue: Yes ]
- Duration of the puncture procedure [ Time Frame: 30 minutes after the beginning of the procedure ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 100 |
| Study Start Date: | January 2010 |
| Study Completion Date: | January 2011 |
| Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: nerve block
median nerve block (6 ml lidocaine 1.5 % with adrenalin 1:200000)
|
Procedure: median nerve block
median nerve block performed using ultrasound guidance
|
|
Experimental: median nerve block after hydro-dissection
median nerve block (6 ml lidocaine 1.5 % with adrenalin 1:200000) after hydro-dissection (glucose 5% solution)
|
Procedure: median nerve block after hydro-dissection
median nerve block performed after hydro-dissection (glucose 5% solution), both using ultrasound guidance
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult patients with an ASA physical status I-II scheduled for elective ambulatory surgery of the hand or wrist involving the median nerve
Exclusion Criteria:
- Patients with type 1 or 2 diabetes mellitus,
- History of clinical or laboratory evidence of abnormal bleeding,
- Infection at the injection site,
- Allergy to local anesthetic,
- Preexisting central or peripheral muscular or neurological disease (for example: carpal tunnel syndrome)
Contacts and Locations
More Information
No publications provided by Hopital Foch
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Marc Fischler, Professor, Hôpital Foch |
| ClinicalTrials.gov Identifier: | NCT01058525 History of Changes |
| Other Study ID Numbers: | 2009/27 |
| Study First Received: | January 27, 2010 |
| Last Updated: | January 22, 2011 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
ClinicalTrials.gov processed this record on May 16, 2013